{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T15:40:38Z","timestamp":1659627638288},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T00:00:00Z","timestamp":1507852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00105-017-4065-6","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T09:08:07Z","timestamp":1507885687000},"page":"876-884","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemtherapie der Vitiligo"],"prefix":"10.1007","volume":"68","author":[{"given":"M.","family":"Meurer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ceric-Dehdari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,13]]},"reference":[{"key":"4065_CR1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamadermatol.2017.0002","volume":"153","author":"JM Bae","year":"2017","unstructured":"Bae JM, Jung HM, Hong BY, Lee JH, Choi WJ, Lee JH, Kim GM (2017) Phototherapy for Vitiligo. A systematic review and met-analysis. JAMA Dermatol 153:666\u2013674","journal-title":"JAMA Dermatol"},{"key":"4065_CR2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/jid.2014.527","volume":"135","author":"M Cavali\u00e9","year":"2015","unstructured":"Cavali\u00e9 M, Ezzedine K, Fontas E, Montaudi\u00e9 H, Castela E, Bahadoran P, Ta\u00efeb A, Lacour JP, Passeron T (2015) Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a\u00a0randomized, double blind, placebo-controlled study. J\u00a0Invest Dermatol 135:970\u2013974","journal-title":"J Invest Dermatol"},{"key":"4065_CR3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40257-015-0153-5","volume":"16","author":"BE Cohen","year":"2015","unstructured":"Cohen BE, Elbuluk N, Mu EW, Orlow SJ (2015) Alternative systemic treatments for Vitiligo: a review. Am J Clin Dermatol 16:463\u2013474","journal-title":"Am J Clin Dermatol"},{"key":"4065_CR4","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1038\/jid.2014.260","volume":"134","author":"BG Craiglow","year":"2014","unstructured":"Craiglow BG, King BA (2014) Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a\u00a0patient with plaque psoriasis. J\u00a0Invest Dermatol 134:2988\u20132990","journal-title":"J Invest Dermatol"},{"key":"4065_CR5","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamadermatol.2015.1520","volume":"151","author":"BG Craiglow","year":"2015","unstructured":"Craiglow BG, King BA (2015) Tofacitinib citrate for the treatment of Vitiligo: a pathogenesis-directed therapy. JAMA Dermatol 151:1110\u20131112","journal-title":"JAMA Dermatol"},{"key":"4065_CR6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","volume":"76","author":"W Damsky","year":"2017","unstructured":"Damsky W, King BA (2017) JAK inhibitors in dermatology: the promise of a\u00a0new drug class. J\u00a0Am Acad Dermatol 76:736\u2013744","journal-title":"J Am Acad Dermatol"},{"key":"4065_CR7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2230.2007.02514.x","volume":"32","author":"ML Dell\u2019Anna","year":"2007","unstructured":"Dell\u2019Anna ML, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin AP, Leone G, Calzavara PG, Westerhof W, Picardo M (2007) Antioxidants and narrow band-UVB in the treatment of vitiligo: a\u00a0double-blind placebo controlled trial. Clin Exp Dermatol 32:631\u2013636","journal-title":"Clin Exp Dermatol"},{"key":"4065_CR8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/dth.12384","volume":"29","author":"M Mofty El","year":"2016","unstructured":"El Mofty M, Essmat S, Youssef R, Sobeih S, Mahgoub D, Ossama S, Saad A, El Tawdy A, Mashaly HM, Saney I, Helal R, Shaker O (2016) The role of systemic steroids and phototherapy in the treatment of stable vitiligo: a\u00a0randomized controlled trial. Dermatol Ther 29:406\u2013412","journal-title":"Dermatol Ther"},{"key":"4065_CR9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/pcmr.12354","volume":"28","author":"V Eleftheriadou","year":"2015","unstructured":"Eleftheriadou V, Thomas K, van Geel N, Hamzavi I, Lim H, Suzuki T, Katayama I, Anbar T, Abdallah M, Benzekri L, Gauthier Y, Harris J, de Silva de Castro CC, Pandya A, Goh BK, Lan CC, Oiso N, Al Issa A, Esmat S, Le Poole C, Lee AY, Parsad D, Ta\u00efeb A, Picardo M, Ezzedine K (2015) Developing core outcome set for vitiligo clinical trials: international e\u2011Delphi consensus. Pigment Cell Melanoma Res 28:363\u2013369","journal-title":"Pigment Cell Melanoma Res"},{"key":"4065_CR10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N (2015) Vitiligo. Lancet 386:74\u201384","journal-title":"Lancet"},{"key":"4065_CR11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2017.07.011","volume":"140","author":"M Frisoli","year":"2017","unstructured":"Frisoli M, Harris JE (2017) Vitiligo: mechanistic insights lead to novel treatments. J\u00a0Allergy Clin Immunol 140:654\u2013662","journal-title":"J Allergy Clin Immunol"},{"key":"4065_CR12","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/jid.2015.126","volume":"135","author":"NB Goldstein","year":"2015","unstructured":"Goldstein NB, Koster MI, Hoaglin LG, Spoelstra NS, Kechris KJ, Robinson SE, Robinson WA, Roop DR, Norris DA, Birlea SA (2015) Narrow band ultraviolet B treatment for human vitiligo is associated with proliferation, migration, and differentiation of melanocyte precursors. J\u00a0Invest Dermatol 135:2068\u20132076","journal-title":"J Invest Dermatol"},{"key":"4065_CR13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/2013.jamadermatol.386","volume":"149","author":"PE Grimes","year":"2013","unstructured":"Grimes PE, Hamzavi I, Lebwohl M, Ortonne JP, Lim HW (2013) The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo. JAMA Dermatol 149:68\u201373","journal-title":"JAMA Dermatol"},{"key":"4065_CR14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archderm.1990.01670270071012","volume":"126","author":"AK Gupta","year":"1990","unstructured":"Gupta AK, Ellis CN, Nickoloff BJ, Goldfarb MT, Ho VC, Rocher LL, Griffiths CE, Cooper KD, Voorhees JJ (1990) Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol 126:339\u2013350","journal-title":"Arch Dermatol"},{"key":"4065_CR15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jaad.2015.09.073","volume":"74","author":"JE Harris","year":"2016","unstructured":"Harris JE, Rashighi M, Nguyen N, Jabbari A, Ulerio G, Clynes R, Christiano AM, Mackay-Wiggan J (2016) Rapid skin repigmentation on oral ruxolitinib in a\u00a0patient with coexistent vitiligo and alopecia areata. J\u00a0Am Acad Dermatol 74:370\u2013371","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"4065_CR16","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","volume":"132","author":"JE Harris","year":"2012","unstructured":"Harris JE, Harris TH, Weninger W, Wherry EJ, Hunter CA, Turka LA (2012) A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T\u2011cell accumulation in the skin. J\u00a0Invest Dermatol 132(7):1869\u20131876","journal-title":"J Invest Dermatol"},{"key":"4065_CR17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1087-0024.2005.200407.x","volume":"10","author":"NK Haass","year":"2005","unstructured":"Haass NK, Herlyn M (2005) Normal human melanocyte homeostasis as a\u00a0paradigmfor understanding melanoma. J\u00a0Investig Dermatol Symp Proc 10:153\u2013163","journal-title":"J Investig Dermatol Symp Proc"},{"key":"4065_CR18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archderm.140.6.677","volume":"140","author":"I Hamzavi","year":"2004","unstructured":"Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H (2004) Parametric modeling of narrowband UV-B phototherapy for vitiligo using a\u00a0novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol 140:677\u2013683","journal-title":"Arch Dermatol"},{"key":"4065_CR19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1056\/NEJMc0805682","volume":"360","author":"J Harms","year":"2009","unstructured":"Harms J, Lautenschl\u00e4ger S, Minder CE, Minder EL (2009) An alpha-melanocyte-stimulating hormone analogue in erythropoetic protoporphyria. N\u00a0Engl J Med 360:306\u2013307","journal-title":"N Engl J Med"},{"key":"4065_CR20","first-page":"42","volume":"15","author":"K Jahn-Bassler","year":"2017","unstructured":"Jahn-Bassler K, Bauer WM, Karlhofer F, Vossen MG, Stingl G (2017) Kombinierte Hoch\u2011\/Niedrig-Dosis-Therapie mit systemischen Glukokortikosteroiden bei schweren Verlaufsformen der Alopecia areate im Kindesalter. J\u00a0Dtsch Dermatol Ges 15:42\u201348","journal-title":"J Dtsch Dermatol Ges"},{"key":"4065_CR21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coi.2016.10.001","volume":"43","author":"K Hirahara","year":"2016","unstructured":"Hirahara K, Schwartz D, Gadina M, Kanno Y, O\u2019Shea JJ (2016) Targeting cytokine signaling in autoimmunity: back to the future and beyond. Curr Opin Immunol 43:89\u201397","journal-title":"Curr Opin Immunol"},{"key":"4065_CR22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1172\/JCI0213729","volume":"110","author":"S Jamal","year":"2002","unstructured":"Jamal S, Schneider RJ (2002) UV-induction of keratinocyte endothelin-1 downregulates E\u2011cadherin in melanocytes and melanoma cells. J\u00a0Clin Invest 110:443\u2013452","journal-title":"J Clin Invest"},{"key":"4065_CR23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0300060513516294","volume":"42","author":"N Karsli","year":"2014","unstructured":"Karsli N, Akcali C, Ozgoztasi O, Kirtak N, Inaloz S (2014) Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy. J\u00a0Int Med Res 42:799\u2013805","journal-title":"J Int Med Res"},{"key":"4065_CR24","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2012.01.038","volume":"69","author":"E Lilly","year":"2013","unstructured":"Lilly E, Lu PD, Borovicka JH, Victorson D, Kwasny MJ, West DP, Kundu RV (2013) Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J\u00a0Am Acad Dermatol 69:e11\u2013e18","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"4065_CR25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamadermatol.2014.1875","volume":"151","author":"HW Lim","year":"2015","unstructured":"Lim HW, Grimes PE, Agbai O, Hamzavi I, Henderson M, Haddican M, Linkner RV, Lebwohl M (2015) Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a\u00a0randomized multicenter trial. JAMA Dermatol 151:42\u201350","journal-title":"JAMA Dermatol"},{"key":"4065_CR26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2017.05.043","volume":"77","author":"LY Liu","year":"2017","unstructured":"Liu LY, Strassner JP, Refat MA, Harris JE, King BA (2017) Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure. J\u00a0Am Acad Dermatol 77:675\u2013682","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4065_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/ced.12664","volume":"41","author":"L Lu","year":"2015","unstructured":"Lu L, Wang S, Fu L, Liu D, Zhu Y, Xu A (2015) Bilobalide protection of normal human melanocytes from hydrogen peroxide-induced oxidative damage via promotion of antioxidase expression and inhibition of endoplasmic reticulum stress. Clin Exp Dermatol 41(1):64. https:\/\/doi.org\/10.1111\/ced.12664","journal-title":"Clin Exp Dermatol"},{"key":"4065_CR28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/bjd.12669","volume":"170","author":"F Meredith","year":"2013","unstructured":"Meredith F, Abbott R (2013) Vitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, U.K. Br J Dermatol 170:565\u2013570","journal-title":"Br J Dermatol"},{"key":"4065_CR29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00105-016-3768-4","volume":"67","author":"M Meurer","year":"2016","unstructured":"Meurer M, Schild M (2016) Therapie der Vitiligo. Hautarzt 67:249\u2013264","journal-title":"Hautarzt"},{"key":"4065_CR30","first-page":"753","volume":"10","author":"D Parsad","year":"1993","unstructured":"Parsad D, Gupta S (1993) Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading vitiligo. Int J Dermatol 10:753\u2013757","journal-title":"Int J Dermatol"},{"key":"4065_CR31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2230.2003.01207.x","volume":"28","author":"D Parsad","year":"2003","unstructured":"Parsad D, Pandhi R, Juneja A (2003) Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol 28:285\u2013287","journal-title":"Clin Exp Dermatol"},{"key":"4065_CR32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0190-9622(90)70028-G","volume":"22","author":"JR Porter","year":"1990","unstructured":"Porter JR, Beuf AH, Lerner AB, Nordlund JJ (1990) The effect of vitiligo on sexual relationships. J\u00a0Am Acad Dermatol 22:221\u2013222","journal-title":"J Am Acad Dermatol"},{"key":"4065_CR33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09546630600791442","volume":"17","author":"M Radmanesh","year":"2006","unstructured":"Radmanesh M, Saedi K (2006) The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients. J\u00a0Dermatolog Treat 17:151\u2013153","journal-title":"J Dermatolog Treat"},{"key":"4065_CR34","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.ajpath.2011.02.016","volume":"178","author":"S Rana","year":"2011","unstructured":"Rana S, Rogers LJ, Halliday GM (2011) Systemic low-dose UVB inhibits CD8 T cells and skin inflammation by alternative and novel mechanisms. Am J Pathol 178:2783\u20132791","journal-title":"Am J Pathol"},{"key":"4065_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3978\/j.issn.2305-5839.2015.11.36","volume":"21","author":"M Rashigi","year":"2015","unstructured":"Rashigi M, Harris JE (2015) Interfering with the IFN-\u03b3\/CXCL10 pathway to develop new targeted treatments for vitiligo. Ann Trans Med 21:343\u2013348. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.11.36","journal-title":"Med"},{"key":"4065_CR36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0378-6323.42905","volume":"74","author":"N Rath","year":"2008","unstructured":"Rath N, Kar HK, Sabhnani S (2008) An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad\/narrow band UVB phototherapy in progressive vitiligo. Indian J Dermatol Venereol Leprol 74:357\u2013360","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"4065_CR37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jid.2016.09.016","volume":"137","author":"JM Richmond","year":"2017","unstructured":"Richmond JM, Bangari DS, Essien KI, Currimbhoy SD, Groom JR, Pandya AG, Youd ME, Luster AD, Harris JE (2017) Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease. J\u00a0Invest Dermatol 137:350\u2013358","journal-title":"J\u00a0Invest Dermatol"},{"key":"4065_CR38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000102044","volume":"215","author":"D Rigopoulos","year":"2007","unstructured":"Rigopoulos D, Gregoriou S, Larios G, Moustou E, Belayeva-Karatza E, Kalogeromitros D (2007) Etanercept in the treatment of vitiligo. Dermatology 215:84\u201385","journal-title":"Dermatology"},{"key":"4065_CR39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2017.02.049","volume":"76","author":"B Rothstein","year":"2017","unstructured":"Rothstein B, Joshipura D, Saraiya A, Abdat R, Ashkar H, Turkowski Y, Sheth V, Huang V, Au SC, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D (2017) Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib. J\u00a0Am Acad Dermatol 76:54\u20131060","journal-title":"J Am Acad Dermatol"},{"key":"4065_CR40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/cei.12168","volume":"174","author":"A Ruiz-Arguelles","year":"2013","unstructured":"Ruiz-Arguelles A, Garc\u00eda-Carrasco M, Jimenez-Brito G, S\u00e1nchez-Sosa S, P\u00e9rez-Romano B, Garc\u00e9s-Eisele J, Camacho-Alarc\u00f3n C, Reyes-N\u00fa\u00f1ez V, Sandoval-Cruz M, Mendoza-Pinto C, L\u00f3pez-Colombo A (2013) Treatment of vitiligo with a\u00a0chimeric monoclonal antibody to CD20: a\u00a0pilot study. Clin Exp Immunol 174:229\u2013236","journal-title":"Clin Exp Immunol"},{"key":"4065_CR41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.270.5237.797","volume":"270","author":"SM Russell","year":"1995","unstructured":"Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone TS, Noguchi M, Markert ML, Buckley RH, O\u2019Shea JJ, Leonard WJ (1995) Mutation of Jak3 in a\u00a0patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797\u2013800","journal-title":"Science"},{"key":"4065_CR42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/0019-5154.152508","volume":"60","author":"LN Sangma","year":"2015","unstructured":"Sangma LN, Nath J, Bhagabati D (2015) Quality of life and psychological morbidity in vitiligo patients: a\u00a0study in a\u00a0teaching hospital from North-East India. Indian J Dermatol 60:142\u2013146","journal-title":"Indian J Dermatol"},{"key":"4065_CR43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00105-015-3751-5","volume":"67","author":"M Schild","year":"2016","unstructured":"Schild M, Meurer M (2016) Vitiligo. Klinik und Pathogenese. Hautarzt 67:173\u2013186","journal-title":"Hautarzt"},{"key":"4065_CR44","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000433424","volume":"231","author":"H Singh","year":"2015","unstructured":"Singh H, Kumaran MS, Bains A, Parsad D (2015) A randomized comparative study of oral corticosteroid minipulse and low-dose oral methotrexate in the treatment of unstable vitiligo. Dermatology 231:286\u2013290","journal-title":"Dermatology"},{"key":"4065_CR45","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.autrev.2017.07.005","volume":"16","author":"R Speeckaert","year":"2017","unstructured":"Speeckaert R, Speeckaert M, De Schepper S, van Geel N (2017) Biomarkers of disese activity in vitiligo: a\u00a0systematic review. Autoimmun Rev 16:937\u2013945","journal-title":"Autoimmun Rev"},{"key":"4065_CR46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6882-11-21","volume":"11","author":"O Sczcurko","year":"2011","unstructured":"Sczcurko O, Shear N, Taddio A, Boon H (2011) Ginkgo biloba for the treatment of vitiligo vulgaris: an open label pilot clinical trial. BMC Complement Altern Med 11:21\u201325","journal-title":"BMC Complement Altern Med"},{"key":"4065_CR47","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2016.12.004","volume":"76","author":"R Shreberk-Hassidim","year":"2017","unstructured":"Shreberk-Hassidim R, Ramot Y, Zlotogorski A (2017) A Janus kinase inhibitors in dermatology: a systematic review. J\u00a0Am Acad Dermatol 76:745\u2013753","journal-title":"J Am Acad Dermatol"},{"key":"4065_CR48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.coi.2016.09.008","volume":"43","author":"JP Strassner","year":"2016","unstructured":"Strassner JP, Harris JE (2016) Understanding mechanisms of autoimmunity through translational research in vitiligo. Curr Opin Immunol 43:81\u201388","journal-title":"Curr Opin Immunol"},{"key":"4065_CR49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","volume":"20","author":"A Ta\u00efeb","year":"2007","unstructured":"Ta\u00efeb A, Picardo M, VETF Members (2007) The definition and assessment of vitiligo: a\u00a0consensus report of the Vitiligo European Task Force. Pigment Cell Res 20:27\u201335","journal-title":"Pigment Cell Res"},{"key":"4065_CR50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","volume":"168","author":"A Ta\u00efeb","year":"2013","unstructured":"Ta\u00efeb A, Alomar A, B\u00f6hm M, Dell\u2019anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G, Moretti S, Nieuweboer-Krobotova L, Olsson MJ, Parsad D, Passeron T, Tanew A, van der Veen W, van Geel N, Whitton M, Wolkerstorfer A, Picardo M (2013) Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol 168:5\u201319","journal-title":"Br J Dermatol"},{"key":"4065_CR51","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/pcmr.12593","volume":"30","author":"N Geel van","year":"2017","unstructured":"van Geel N, Boniface K, Seneschal J, Jacquemin C, Speeckaert R, Wolkerstorfer A, Bekkenk M, Lommerts JE, Hamzavi I, Pandya A, Eleftheriadou V, Ezzedine K, Giannarelli D, Gnarra M, Sperduti I, Prinsen C, Harris J, Taieb A, Picardo M (2017) Meeting report: vitiligo global issues consensus conference workshop \u201coutcome measurement instruments\u201d and vitiligo international symposium, Rome, Nov 30-Dec 3rd. Pigment Cell Melanoma Res 30:436\u2013443","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"4065_CR52","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","volume":"174","author":"XX Wang","year":"2016","unstructured":"Wang XX, Wang QQ, Wu JQ, Jiang M, Chen L, Zhang CF, Xiang LH (2016) Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a\u00a0potential clinical marker for vitiligo. Br J Dermatol 174(6):1318\u20131326","journal-title":"Br J Dermatol"},{"key":"4065_CR53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bjd.14016","volume":"173","author":"KC Webb","year":"2015","unstructured":"Webb KC, Tung R, Winterfield LS, Gottlieb AB, Eby JM, Henning SW, Le Poole IC (2015) Tumour necrosis factor-\u03b1 inhibition can stabilize disease in progressive vitiligo. Br J Dermatol 173:641\u2013650","journal-title":"Br J Dermatol"},{"key":"4065_CR54","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrrheum.2017.23","volume":"13","author":"KL Winthrop","year":"2017","unstructured":"Winthrop KL (2017) The emerging safety profile of JAK inhibitors in rheumatic disease. Nat Rev Rheumatol 13:234\u2013243","journal-title":"Nat Rev Rheumatol"},{"key":"4065_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003263.pub5","author":"ME Whitton","year":"2015","unstructured":"Whitton ME, Pinart M, Batchelor J, Leonardi-Bee J, Gonz\u00e1lez U, Jiyad Z, Eleftheriadou V, Ezzedine K (2015) Interventions for vitiligo. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD003263.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"4065_CR56","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.2006.07584.x","volume":"156","author":"CS Wu","year":"2007","unstructured":"Wu CS, Lan CC, Wang LF, Chen GS, Wu CS, Yu HS (2007) Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo. Br J Dermatol 156:122\u2013129","journal-title":"Br J Dermatol"},{"key":"4065_CR57","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.0906-6705.2004.00221.x","volume":"13","author":"CS Wu","year":"2004","unstructured":"Wu CS, Yu CL, Wu CS, Lan CC, Yu HS (2004) Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes. Exp Dermatol 13:755\u2013763","journal-title":"Exp Dermatol"},{"key":"4065_CR58","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archderm.143.5.578","volume":"143","author":"SS Yones","year":"2007","unstructured":"Yones SS, Palmer RA, Garibaldinos TM, Hawk JL (2007) Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy. Arch Dermatol 143:578\u2013584","journal-title":"Arch Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-017-4065-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4065-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4065-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T15:13:51Z","timestamp":1659626031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-017-4065-6"}},"subtitle":["Bilanz und aktuelle Entwicklungen"],"short-title":[],"issued":{"date-parts":[[2017,10,13]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["4065"],"URL":"https:\/\/doi.org\/10.1007\/s00105-017-4065-6","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,13]]}}}